Effective Heart Therapy That Slashes Costs Identified by American Heart Association
Updated: Jul 19
The American Heart Association (AHA) has identified a major new heart disease risk and an effective method that slashes the cost of treating it by more than 80 percent.
The AHA Statement identifies LOW LEVELS of heavy metals such as lead, cadmium and arsenic as major risks. These metals are found in drinking water, soil, consumer products, food, and smoke from wildfires & cigarettes. A recent Consumer Reports study found high levels in popular baby foods. The metals accumulate over time in humans, causing chronic inflammation and other disease-triggering problems.
A therapy that removes heavy metals is shown in studies to be more effective at treating a type of heart disease that affects more than 50 million people globally, compared to surgery or higher priced drugs. A comparative study found that costs are $8,000 - $16,000 compared to $78,000 - $116,000 for standard care.
The AHA Scientific Statement recognizes the therapy this way:
"Chelating agents with high affinity for toxic metals... remove contaminant metals, especially lead and cadmium, from the human body. A systematic review of all edetate clinical trials suggested a signal of benefit, with optimal clinical effect in patients with Peripheral Artery Disease and diabetes.” Contaminant Metals as Cardiovascular Risk Factors: A Scientific Statement From the American Heart Association
That same therapy was proven safe and effective at reducing all causes of death by more than 40% in a $35 million clinical trial sponsored by the U.S. National Institutes of Health. A further trial is underway and results are expected in early 2024.
Implications for heart care across America include:
Filling a gap in diagnosis for people who have hypertension or heart conditions but don’t have standard heart disease risk factors.
Healthcare professionals will have to learn how to test for and treat this new heart disease risk.
Good news for 10 million Americans with Peripheral Artery Disease (PAD). Severely ill PAD patients improved significantly when the metals were removed non-invasively. The studies were performed at Mt. Sinai medical center under supervision of the Chief author of the AHA statement.
The 100 years of discovery that led to these metals being declared as heart risk factors, and the ways of getting rid of them, are described in a new book, Discovering the Nature of Longevity: Restoring the heart and body by targeting hidden stress (2023), recommended by the American Institute of Stress, and with a Foreword by the Chief Author of the AHA statement, Dr. Gervasio Lamas, Chief of Cardiology at Columbia University.
In related news, the New York Times exposed unnecessary surgeries leading to amputations. Read the full text on Yahoo here. The non-invasive therapy described by the American Heart Association is designed to prevent this kind of abuse.